CareSync, a Tampa, Fla.-based provider of software and services for chronic disease management, secured $18m in Series B funding.
Backers included the Merck Global Health Innovation Fund (Merck GHI), Greycroft Partners and Harbert Venture Partners, as well as existing investors Tullis Health Investors, Clearwell Group, CDH Solutions and Travis Bond.
The company intends to use the funds to expand its workforce (over the next 18 months, it plans to hire an additional 500 employees) and continue to advance its technology.
Founded in 2011 by Travis Bond, CEO, CareSync provides software and services for chronic disease management, combining technology with 24/7 nursing services to facilitate care coordination among patients, family and caregivers and all providers.
The company now serves more than 100 locations that care for more than 300,000 chronically ill Medicare beneficiaries.